Neuvivo’s NP001 – an Immune System Regulator – Has Effect on Biomarkers of Microbial Translocation in ALS Patients Responsive to Treatment

PALO ALTO, Calif. and EDINBURGH, Scotland, June 2, 2022 /PRNewswire/ -- Today, at the ENCALS Conference (European Network to Cure ALS) Neuvivo presented an abstract titled: "Plasma biomarkers of microbial translocation are modulated in ALS patients clinically responsive to NP001"....

Click to view original post